Liuying Township, Taiwan Clinical Trials

A listing of Liuying Township, Taiwan clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 89 clinical trials
Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)

MAGIC-8 is a two-arm, multicenter, phase 1b/2 study to assess the efficacy of immunotherapy with either Nivolumab (anti-PD-1) or Nivolumab plus BMS-986253 combined with ADT using Degarelix (LHRH antagonist) for men with hormone-sensitive prostate cancer and a rising prostate-sepcific antigen (PSA). The purpose of this study is to see whether …

external beam radiation therapy
prostatectomy
cancer
adenocarcinoma of prostate
degarelix
  • 3 views
  • 27 Jan, 2021
  • 2 locations
Therapeutic Vaccine Plus PD-1 Knockout in Prostate Cancer Treatment

This study is to evaluate the safety and efficacy of a therapeutic vaccine in combination with PD-1 knockout T cells in the treatment of advanced prostate cancer.

androgens
vaccine therapy
testosterone
metastasis
  • 9 views
  • 22 Jan, 2021
177Lu-PSMA-R2 in Patients With PSMA Positive Progressive Metastatic Castration Resistant Prostate Cancer

This Phase 1/2 study is intended to investigate the safety, tolerability, and radiation dosimetry of 177Lu-PSMA-R2 and further assess preliminary efficacy data in patients with metastatic castration-resistant prostate cancer (mCRPC). The Phase 1 portion of the study will determine the recommended dose of 177Lu-PSMA-R2 for radio-ligand therapy (RLT) of mCRPC, …

platelet count
cancer
castration-resistant prostate cancer
pet/ct scan
adenocarcinoma of prostate
  • 130 views
  • 19 Jul, 2021
  • 9 locations
BEACON: HDR Brachytherapy EBRT and STAD for the Treatment of Local and Pelvic Recurrence of Prostate Cancer After Radiation Therapy

The purpose of this study is to evaluate the safety and effectiveness of combining high-dose-rate (HDR) brachytherapy with external beam radiotherapy (EBRT) to the pelvis and 6 months of hormonal therapy, otherwise known as short term androgen deprivation therapy (STAD), as treatment for prostate cancer that has come back in …

  • 8 views
  • 25 Jan, 2021
  • 1 location
Trial of ARV-110 in Patients With Metastatic Castration Resistant Prostate Cancer

Phase 1/2 dose escalation study to assess the safety and tolerability of ARV-110 in men with mCRPC who have progressed on prior approved systemic therapies for their castrate resistant disease (one of which must be enzalutamide or abiraterone).

abiraterone
castration-resistant prostate cancer
enzalutamide
medical castration
metastatic castration-resistant prostate cancer
  • 83 views
  • 02 Jul, 2021
  • 72 locations
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

This is a phase I/II open label multi-center study in which patients will receive low dose targeted busulfan followed by infusion of autologous CD34+ selected bone marrow or mobilized peripheral blood cells transduced with the G2SCID vector. Subjects will be enrolled over 3 years and be followed for 2 years …

  • 24 views
  • 30 Apr, 2021
  • 5 locations
RGX-121 Gene Therapy in Patients With MPS II (Hunter Syndrome)

RGX-121 is a gene therapy which is intended to deliver a functional copy of the iduronate-2-sulfatase (IDS) gene to the central nervous system. This study is a safety and dose ranging study to determine whether RGX-121 is safe and tolerated by patients with MPS II.

  • 274 views
  • 15 Jun, 2021
  • 5 locations
ONE-SHOT Trial - Ultra-hypofractionated Single-dose SBRT for Prostate Cancer

The main objective of the phase I/II trial is to determine the safety and efficacy of a single fraction SBRT at a dose of 19 Gy in patients with localized prostate cancer.

adenocarcinoma
adenocarcinoma of prostate
  • 4 views
  • 24 Jan, 2021
  • 1 location
Phase I/II Study of Hydroxychloroquine With Itraconazole With Biochemically Recurrent Prostate Cancer

Recent pre-clinical work has suggested that Itraconazole has an anti-cancer effect that works synergistically with hydroxychloroquine. This may delay the need for androgen deprivation therapy (ADT) and its associated toxicities in men with biochemically recurrent (BCR) prostate cancer. This study aims to determine feasibility, safety and efficacy of suba-itraconazole (SI) …

androgen suppression
prostatectomy
antiandrogen therapy
testosterone
serum testosterone
  • 1 views
  • 11 Mar, 2021
  • 1 location
Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy

The purpose of this study is to test the safety, tolerability, and effectiveness of the investigational drug nivolumab (Opdivo) in combination with high dose radiation. Investigators also want to see if these study drugs help to delay the progression of prostate cancer.

external beam radiation therapy
brachytherapy
androgen suppression
antiandrogen therapy
cancer
  • 3 views
  • 09 Jul, 2021
  • 1 location